Figure 10.

Cross section of device demonstrating bone-device interface. (hematoxylin and eosin 0.4×) in animal 2. Twenty six weeks after implantation.

Cross section of device demonstrating bone-device interface. (hematoxylin and eosin 0.4×) in animal 2. Twenty six weeks after implantation.